Split History
ICCC split history picture
ImmuCell (ICCC) has 2 splits in our ICCC split history database. The first split for ICCC took place on July 24, 1990. ICCC's second split took place on July 25, 1990. This was a 1 for 100 reverse split, meaning for each 100 shares of ICCC owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 10 share position following the split.

When a company such as ImmuCell conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the ICCC split history from start to finish, an original position size of 1000 shares would have turned into 10 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into ImmuCell shares, starting with a $10,000 purchase of ICCC, presented on a split-history-adjusted basis factoring in the complete ICCC split history. ICCC split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 10/01/2012
End date: 09/27/2022
Start price/share: $5.01
End price/share: $7.57
Dividends collected/share: $0.00
Total return: 51.10%
Average Annual Total Return: 4.22%
Starting investment: $10,000.00
Ending investment: $15,115.15
Years: 9.99
ImmuCell is an animal health company. Co. focuses on creating products that improve the health and productivity of dairy and beef cattle. The First Defense® product line provides bovine antibodies that newborn calves need but are unable to produce on their own immediately after birth. The target disease, calf scours (bovine enteritis), causes diarrhea and dehydration in newborn calves and often leads to serious sickness and even death. The First Defense® product line is an orally delivered scours preventive product on the market for calves with claims against E. coli, coronavirus and rotavirus. Co.'s Beyond Vaccination® marketing campaign focuses on providing antibodies without vaccination. According to our ICCC split history records, ImmuCell has had 2 splits.
Date Ratio
07/24/19901 for 1
07/25/19901 for 100
ICCC is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

ICLR Split History
ICUI Split History
IDRA Split History
IDXG Split History
IDXX Split History
IGC Split History
IIN Split History
ILMN Split History
IMMY Split History
IMNP Split History

Also explore: ICCC shares outstanding history

Email EnvelopeFree ICCC Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Avenue Therapeutics, Inc. (ATXI)
Annaly Capital Management, Inc. (NLY)
CohBar, Inc. (CWBR)
TOP Ships Inc. (TOPS)
Sonnet BioTherapeutics Holdings, Inc. (SONN)
Nabriva Therapeutics plc (NBRV)
NeuroBo Pharmaceuticals, Inc. (NRBO)
First Wave BioPharma, Inc. (FWBI)
Palatin Technologies, Inc. (PTIN)
TD Holdings, Inc. (GLG )
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

ICCC Insider Buying

ICCC Split History | www.SplitHistory.com | Copyright © 2013 - 2022, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.